Your browser doesn't support javascript.
loading
A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended-Release) in Adolescents with ADHD.
Nasser, Azmi; Liranso, Tesfaye; Adewole, Toyin; Fry, Nicholas; Hull, Joseph T; Chowdhry, Fatima; Busse, Gregory D; Melyan, Zare; Cutler, Andrew J; Findling, Robert L; Schwabe, Stefan.
Affiliation
  • Nasser A; Nasser, PhD, Liranso, PhD, Adewole, MD, Fry, Hull, PhD, Chowdhry, MD, Busse, PhD, Melyan, PhD, Schwabe, MD, PhD, Supernus Pharmaceuticals, Inc., Rockville, MD, USA; Cutler, MD, SUNY Upstate Medical University, and Neuroscience Education Institute, Lakewood Ranch, FL, USA; Findling, MD, Virginia Comm
  • Liranso T; Nasser, PhD, Liranso, PhD, Adewole, MD, Fry, Hull, PhD, Chowdhry, MD, Busse, PhD, Melyan, PhD, Schwabe, MD, PhD, Supernus Pharmaceuticals, Inc., Rockville, MD, USA; Cutler, MD, SUNY Upstate Medical University, and Neuroscience Education Institute, Lakewood Ranch, FL, USA; Findling, MD, Virginia Comm
  • Adewole T; Nasser, PhD, Liranso, PhD, Adewole, MD, Fry, Hull, PhD, Chowdhry, MD, Busse, PhD, Melyan, PhD, Schwabe, MD, PhD, Supernus Pharmaceuticals, Inc., Rockville, MD, USA; Cutler, MD, SUNY Upstate Medical University, and Neuroscience Education Institute, Lakewood Ranch, FL, USA; Findling, MD, Virginia Comm
  • Fry N; Nasser, PhD, Liranso, PhD, Adewole, MD, Fry, Hull, PhD, Chowdhry, MD, Busse, PhD, Melyan, PhD, Schwabe, MD, PhD, Supernus Pharmaceuticals, Inc., Rockville, MD, USA; Cutler, MD, SUNY Upstate Medical University, and Neuroscience Education Institute, Lakewood Ranch, FL, USA; Findling, MD, Virginia Comm
  • Hull JT; Nasser, PhD, Liranso, PhD, Adewole, MD, Fry, Hull, PhD, Chowdhry, MD, Busse, PhD, Melyan, PhD, Schwabe, MD, PhD, Supernus Pharmaceuticals, Inc., Rockville, MD, USA; Cutler, MD, SUNY Upstate Medical University, and Neuroscience Education Institute, Lakewood Ranch, FL, USA; Findling, MD, Virginia Comm
  • Chowdhry F; Nasser, PhD, Liranso, PhD, Adewole, MD, Fry, Hull, PhD, Chowdhry, MD, Busse, PhD, Melyan, PhD, Schwabe, MD, PhD, Supernus Pharmaceuticals, Inc., Rockville, MD, USA; Cutler, MD, SUNY Upstate Medical University, and Neuroscience Education Institute, Lakewood Ranch, FL, USA; Findling, MD, Virginia Comm
  • Busse GD; Nasser, PhD, Liranso, PhD, Adewole, MD, Fry, Hull, PhD, Chowdhry, MD, Busse, PhD, Melyan, PhD, Schwabe, MD, PhD, Supernus Pharmaceuticals, Inc., Rockville, MD, USA; Cutler, MD, SUNY Upstate Medical University, and Neuroscience Education Institute, Lakewood Ranch, FL, USA; Findling, MD, Virginia Comm
  • Melyan Z; Nasser, PhD, Liranso, PhD, Adewole, MD, Fry, Hull, PhD, Chowdhry, MD, Busse, PhD, Melyan, PhD, Schwabe, MD, PhD, Supernus Pharmaceuticals, Inc., Rockville, MD, USA; Cutler, MD, SUNY Upstate Medical University, and Neuroscience Education Institute, Lakewood Ranch, FL, USA; Findling, MD, Virginia Comm
  • Cutler AJ; Nasser, PhD, Liranso, PhD, Adewole, MD, Fry, Hull, PhD, Chowdhry, MD, Busse, PhD, Melyan, PhD, Schwabe, MD, PhD, Supernus Pharmaceuticals, Inc., Rockville, MD, USA; Cutler, MD, SUNY Upstate Medical University, and Neuroscience Education Institute, Lakewood Ranch, FL, USA; Findling, MD, Virginia Comm
  • Findling RL; Nasser, PhD, Liranso, PhD, Adewole, MD, Fry, Hull, PhD, Chowdhry, MD, Busse, PhD, Melyan, PhD, Schwabe, MD, PhD, Supernus Pharmaceuticals, Inc., Rockville, MD, USA; Cutler, MD, SUNY Upstate Medical University, and Neuroscience Education Institute, Lakewood Ranch, FL, USA; Findling, MD, Virginia Comm
  • Schwabe S; Nasser, PhD, Liranso, PhD, Adewole, MD, Fry, Hull, PhD, Chowdhry, MD, Busse, PhD, Melyan, PhD, Schwabe, MD, PhD, Supernus Pharmaceuticals, Inc., Rockville, MD, USA; Cutler, MD, SUNY Upstate Medical University, and Neuroscience Education Institute, Lakewood Ranch, FL, USA; Findling, MD, Virginia Comm
Psychopharmacol Bull ; 51(2): 43-64, 2021 03 16.
Article in En | MEDLINE | ID: mdl-34092822
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Attention Deficit Disorder with Hyperactivity / Viloxazine Type of study: Clinical_trials Limits: Adolescent / Child / Humans Language: En Journal: Psychopharmacol Bull Year: 2021 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Attention Deficit Disorder with Hyperactivity / Viloxazine Type of study: Clinical_trials Limits: Adolescent / Child / Humans Language: En Journal: Psychopharmacol Bull Year: 2021 Document type: Article Country of publication: United States